Description: With the persistent low interest rate environment, fast pace of regulatory changes and the size of insurers' back-books relative to new business, it is no surprise that insurers have become increasingly focused on their management of non-guaranteed elements ('NGE') for life and annuity business. Come explore the opportunities and challenges offered by NGE management, with consideration for market trends, regulation, the new ASOP 2 and emerging case law.

Description: Are Accelerated Underwriting (AU) programs performing as expected? As mortality experience will (hopefully) be slow to emerge, it is pivotal that we look at alternative methods of monitoring early performance. From random hold outs, to post-issue APS's, and post-issue prescription profiles, explore popular monitoring techniques and lessons learned so far. Focus on confusion matrices that provide an early indication of mortality slippage relative to fluid-based underwriting decisions. Finally, explore statistical methods to determine what constitutes credibility and identify opportunities to think about mortality slippage more robustly.

Description: As accelerated underwriting continues to evolve, it is a delicate balance to ensure these programs are managed effectively for both short- and long-term results. And there's debate about whether these programs are getting too aggressive. Join panelists as they share their viewpoints on the state of accelerated underwriting, the data sources, models, tools and techniques commonly used, how the landscape is destined to change with more dynamic approaches in underwriting, and how best to monitor these programs, and the impacts of these programs to carriers and the industry as a whole.

Description: Join us as some of the hottest topics are debated by a multi-discipline panel of industry experts focusing on potential impacts to key performance metrics. Will their arguments sway you? The final say is yours as audience polling decides which side wins the day. This fiery clash will include such topics as: what's really driving mortality?, can I really assume 'all else equal' when making underwriting changes?,I dare you to step over this line - is there an inflection point in fluidless underwriting as qualification rates increase with continued upward pressure?,how many years to credible mortality?, can I really tell if this is working anytime soon? and how effective are leading performance indicators? By attending the

Description: The qualification of life insurance under Sections 7702 and 7702A can often be complex and result in inadvertent instance of noncompliance for life insurance companies. This session with explore the complexities of product tax compliance from a due diligence perspective as well as discuss other alternatives companies may have as they administer reductions in benefit under Section 7702A.

Description: Insurance carriers today must balance a multitude of factors to remain relevant and innovate- -process improvements and efficiency (automated or traditional); -customer experience (less intrusive, more data); -distribution (aging traditional, product focus, emerging opportunities); and -mortality. While these factors are not new, true innovation in these areas require a convergence of engagement among actuaries, underwriters and data scientists to determine the specific pain points and appreciate both the benefits and consequences of various paths. Explore examples of how best to approach these topics, engage different disciplines, avoid pitfalls and ensure a holistic view. Real life examples and lessons learned will be shared during this session.

Description: Electronic Health Records are here to stay. Take a deep dive into the world of electronic health records and how the industry is poised to utilize this new form of digital medical data to transform the way policies are underwritten and ultimately, transforming the client experience. Listen to industry experts speak about what they are doing to use this data most effectively and how this ultimately develops into ground-breaking solutions for the industry.

Description: 2021 Life Meeting - Session 4E: LDTI Earnings Analysis for Life Products 8.31.21 Recording

Description: LDTI requires that reinsurance recoverables be recognized in a manner consistent with the liabilities of underlying direct contracts. Consider implications of multiple ceded reinsurance contracts (e.g., coinsurance and YRT on the same business) and how this impacts the calculation of the net premium ratio (NPR) and other related approximations. Explore different options when only some of the policies within a cohort are reinsured. Multiple interpretations of the components of the NPR formula exist. Two main approaches will be presented-standalone and integrated approach. Other considerations to be discussed include implications of closed-block reinsurance transactions at transition and subsequent to transition, contra-DAC, market risk benefits. Finally, explore the short-duration YRT approximation (1/2 Cx) compared to the long-duration calculation.

Description: ClubVita Session Series Longevity trend risk still exists even for the largest portfolios. Explore the differences in longevity improvements between different populations, how to categorize subpopulations with different trend risk characteristics, and how to use this categorization to reduce longevity trend basis risk.